Ignite Creation Date:
2025-12-24 @ 6:29 PM
Ignite Modification Date:
2025-12-24 @ 6:29 PM
Study NCT ID:
NCT03769168
Status:
COMPLETED
Last Update Posted:
2025-10-16
First Post:
2018-11-21
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-11-21
First Submit QC Date:
None
Study First Post Date:
2018-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-05-02
Results First Submit QC Date:
None
Results First Post Date:
2025-05-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-08
Last Update Post Date:
2025-10-16
Last Update Post Date Type:
ESTIMATED